105 related articles for article (PubMed ID: 26957561)
1. Tumor Evolution Inferred by Patterns of microRNA Expression through the Course of Disease, Therapy, and Recurrence in Breast Cancer.
Dadiani M; Bossel Ben-Moshe N; Paluch-Shimon S; Perry G; Balint N; Marin I; Pavlovski A; Morzaev D; Kahana-Edwin S; Yosepovich A; Gal-Yam EN; Berger R; Barshack I; Domany E; Kaufman B
Clin Cancer Res; 2016 Jul; 22(14):3651-62. PubMed ID: 26957561
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA expression and gene regulation drive breast cancer progression and metastasis in PyMT mice.
Nogales-Cadenas R; Cai Y; Lin JR; Zhang Q; Zhang W; Montagna C; Zhang ZD
Breast Cancer Res; 2016 Jul; 18(1):75. PubMed ID: 27449149
[TBL] [Abstract][Full Text] [Related]
3. The role of miRNAs as a predictor of multicentricity in breast cancer.
Akbulut H; Ersoy YE; Coskunpinar E; Gucin Z; Yildiz S; Malya FU; Hasturk B; Muslumanoglu M
Mol Biol Rep; 2019 Apr; 46(2):1787-1796. PubMed ID: 30707415
[TBL] [Abstract][Full Text] [Related]
4. Clinical Relevance of Circulating, Cell-Free and Exosomal microRNAs in Plasma and Serum of Breast Cancer Patients.
Schwarzenbach H
Oncol Res Treat; 2017; 40(7-8):423-429. PubMed ID: 28683441
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-9 is associated with epithelial-mesenchymal transition, breast cancer stem cell phenotype, and tumor progression in breast cancer.
Gwak JM; Kim HJ; Kim EJ; Chung YR; Yun S; Seo AN; Lee HJ; Park SY
Breast Cancer Res Treat; 2014 Aug; 147(1):39-49. PubMed ID: 25086633
[TBL] [Abstract][Full Text] [Related]
6. [microRNA expression in breast development and breast cancer].
Avril S
Pathologe; 2013 Nov; 34 Suppl 2():195-200. PubMed ID: 24196612
[TBL] [Abstract][Full Text] [Related]
7. Next generation sequencing profiling identifies miR-574-3p and miR-660-5p as potential novel prognostic markers for breast cancer.
Krishnan P; Ghosh S; Wang B; Li D; Narasimhan A; Berendt R; Graham K; Mackey JR; Kovalchuk O; Damaraju S
BMC Genomics; 2015 Sep; 16():735. PubMed ID: 26416693
[TBL] [Abstract][Full Text] [Related]
8. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer.
Vilquin P; Donini CF; Villedieu M; Grisard E; Corbo L; Bachelot T; Vendrell JA; Cohen PA
Breast Cancer Res; 2015 Jan; 17(1):13. PubMed ID: 25633049
[TBL] [Abstract][Full Text] [Related]
10. miRNAs 484 and 210 regulate Pax-5 expression and function in breast cancer cells.
Harquail J; LeBlanc N; Ouellette RJ; Robichaud GA
Carcinogenesis; 2019 Aug; 40(8):1010-1020. PubMed ID: 30605519
[TBL] [Abstract][Full Text] [Related]
11. Global Analysis of miRNA-mRNA Interaction Network in Breast Cancer with Brain Metastasis.
Li Z; Peng Z; Gu S; Zheng J; Feng D; Qin Q; He J
Anticancer Res; 2017 Aug; 37(8):4455-4468. PubMed ID: 28739740
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Value of a BCSC-associated MicroRNA Signature in Hormone Receptor-Positive HER2-Negative Breast Cancer.
Gong C; Tan W; Chen K; You N; Zhu S; Liang G; Xie X; Li Q; Zeng Y; Ouyang N; Li Z; Zeng M; Zhuang S; Lau WY; Liu Q; Yin D; Wang X; Su F; Song E
EBioMedicine; 2016 Sep; 11():199-209. PubMed ID: 27566954
[TBL] [Abstract][Full Text] [Related]
13. Correlative Analysis of miRNA Expression and Oncotype Dx Recurrence Score in Estrogen Receptor Positive Breast Carcinomas.
Emmadi R; Canestrari E; Arbieva ZH; Mu W; Dai Y; Frasor J; Wiley E
PLoS One; 2015; 10(12):e0145346. PubMed ID: 26717565
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-340 inhibits the migration, invasion, and metastasis of breast cancer cells by targeting Wnt pathway.
Mohammadi-Yeganeh S; Paryan M; Arefian E; Vasei M; Ghanbarian H; Mahdian R; Karimipoor M; Soleimani M
Tumour Biol; 2016 Jul; 37(7):8993-9000. PubMed ID: 26758430
[TBL] [Abstract][Full Text] [Related]
15. microRNA-associated progression pathways and potential therapeutic targets identified by integrated mRNA and microRNA expression profiling in breast cancer.
Buffa FM; Camps C; Winchester L; Snell CE; Gee HE; Sheldon H; Taylor M; Harris AL; Ragoussis J
Cancer Res; 2011 Sep; 71(17):5635-45. PubMed ID: 21737487
[TBL] [Abstract][Full Text] [Related]
16. Circulating Pre-microRNA-488 in Peripheral Blood Is a Potential Biomarker for Predicting Recurrence in Breast Cancer.
Masuda T; Shinden Y; Noda M; Ueo H; Hu Q; Yoshikawa Y; Tsuruda Y; Kuroda Y; Ito S; Eguchi H; Ohno S; Mimori K
Anticancer Res; 2018 Aug; 38(8):4515-4523. PubMed ID: 30061217
[TBL] [Abstract][Full Text] [Related]
17. The microRNA-218 and ROBO-1 signaling axis correlates with the lymphatic metastasis of pancreatic cancer.
He H; Di Y; Liang M; Yang F; Yao L; Hao S; Li J; Jiang Y; Jin C; Fu D
Oncol Rep; 2013 Aug; 30(2):651-8. PubMed ID: 23733161
[TBL] [Abstract][Full Text] [Related]
18. MicroRNAs with prognostic potential for metastasis in clear cell renal cell carcinoma: a comparison of primary tumors and distant metastases.
Heinzelmann J; Unrein A; Wickmann U; Baumgart S; Stapf M; Szendroi A; Grimm MO; Gajda MR; Wunderlich H; Junker K
Ann Surg Oncol; 2014 Mar; 21(3):1046-54. PubMed ID: 24242678
[TBL] [Abstract][Full Text] [Related]
19. Expression of miR-18a and miR-210 in Normal Breast Tissue as Candidate Biomarkers of Breast Cancer Risk.
Shidfar A; Costa FF; Scholtens D; Bischof JM; Sullivan ME; Ivancic DZ; Vanin EF; Soares MB; Wang J; Khan SA
Cancer Prev Res (Phila); 2017 Jan; 10(1):89-97. PubMed ID: 27789587
[TBL] [Abstract][Full Text] [Related]
20. A MicroRNA cluster at 14q32 drives aggressive lung adenocarcinoma.
Nadal E; Zhong J; Lin J; Reddy RM; Ramnath N; Orringer MB; Chang AC; Beer DG; Chen G
Clin Cancer Res; 2014 Jun; 20(12):3107-17. PubMed ID: 24833665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
